52 Week Range
As of on the Toronto Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Cronos Group Reports 2021 First Quarter Results
Cronos Group Qtrly Loss Per Share $0.31
Cronos Group Reports Q3 Earnings Per Share Diluted - Continuing Operations $0.19
Cronos Group Inc is a cannabinoid company. The Company is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivations Ltd, Cronos Israel G.S. Manufacturing Ltd, Cronos Israel G.S. Store Ltd and Cronos Israel G.S. Pharmacies Ltd.
Biotechnology & Drugs
Suite 300, 111 Peter Street
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
* CRONOS GROUP INC - QTRLY CONSOLIDATED NET REVENUE $8.43 MILLION VERSUS $3 MILLION
Altria Group Inc <MO.N> said on Friday Chief Executive Officer Howard Willard has stepped down, ending a near two-year tumultuous term at the helm marked by heightened scrutiny of the tobacco giant's bet on e-cigarette maker Juul.
* CRONOS GROUP REPORTS 2019 FOURTH QUARTER AND FULL-YEAR RESULTS
* CRONOS GROUP - IN ACCORDANCE WITH INVESTOR RIGHTS AGREEMENT AND ALTRIA'S SUBMISSION, BOARD ELECTED HEATHER NEWMAN AS A DIRECTOR Source text: (https://bit.ly/39ZeNnv) Further company coverage:
* CRONOS GROUP TO RESTATE CERTAIN 2019 UNAUDITED INTERIM FINANCIAL STATEMENTS
* CRONOS GROUP TO DELAY 2019 Q4 AND FULL-YEAR EARNINGS RELEASE AND CONFERENCE CALL
Cronos Group Inc <CRON.TO> <CRON.N> and Tilray Inc <TLRY.O> both reported selling prices that nearly halved, while expenses for both the Canadian pot producers soared in the third quarter.
Cronos Group Inc reported a bigger quarterly loss on Tuesday, as the Canadian marijuana producer was weighed down by lower margins and surge in expenses.
Canada's Cronos Group <CRON.TO> shares reversed course to trade down after the pot company forecast a wider second-half loss compared to the first, even as sales soar, as it spends on developing new products and expanding abroad.
Canadian marijuana company Cronos Group reported a wider quarterly core loss on Thursday, as it struggled with rising costs.
Marlboro cigarette maker Altria Group Inc announced a $1.8 billion investment in Cronos Group Inc on Friday, which could give it up to 55-percent ownership of the Canadian cannabis producer.
Canada's Cronos Group Inc said on Friday Marlboro cigarette maker Altria Group Inc will invest $1.8 billion in the cannabis producer, giving it a 45 percent stake in the company.
Marlboro cigarette maker Altria Group Inc <MO.N> is in discussions with Canadian cannabis producer Cronos Group Inc <CRON.TO> about making a possible investment, Cronos said on Monday.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.